Related MeSH Hierarchy (4)
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Anemia » Anemia, Hemolytic » Anemia, Hemolytic, Congenital » Thalassemia
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hemoglobinopathies » Thalassemia
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Anemia, Hemolytic, Congenital » Thalassemia
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Hemoglobinopathies » Thalassemia
Description
A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. MeSH
Hierarchy View
Subtype Terms (3)
alpha-Thalassemia
2 drugs (1 approved, 1 experimental)
beta-Thalassemia
111 drugs (56 approved, 55 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (13)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (14)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 3 Indications (24)
Organization Involved with Phase 2 Indications (95)
Azienda Ospedaliera Villa Sofia
Case Western Reserve University
Children's National Medical Center
Guangdong Yike Gene Science and Technology CO.,Ltd
Hangzhou Zede Pharma-Tech Co., Ltd.
Hôpital universitaire Robert-Debré
Laikο General Hospital, Athens
La Jolla Pharmaceutical Company
Los Angeles Biomedical Research Institute
Methodist Cancer Center, Houston, Texas
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Ospedale Maggiore San Giovanni Bosco
Rare Partners srl Impresa Sociale
Shanghai Bioray Laboratory Inc.
State University of New York, Buffalo
Steven & Alexandra Cohen Children's Medical Center, New York
The Oncology Institute Long Beach
University of Alabama, Birmingham
University of California, Los Angeles
University of Campania Luigi Vanvitelli
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Southern California
Vita-Salute University of Milano. Italy
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (12)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
